InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
TLR4-based adjuvant - MPLA-SM VacciGrade™ | Leptospira Lipid A Is a Potent Adjuvant That Induces Sterilizing Immunity aga... | 2023 | Vaccines (Basel) | Varma V.P. et al. | DOI: 10.3390/vaccines11121824 |
PlasmoTest™ - Mycoplasma Detection Kit | Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That I... | 2023 | Cancer Res Commun. | Kazi A. et al. | DOI: 10.1158/2767-9764.CRC-23-0222 |
QUANTI-Luc™: Luciferase Detection Reagent | Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrins... | 2023 | J Immunother Cancer | Li J. et al. | DOI: 10.1136/jitc-2023-007625 |
RAW-Lucia™ ISG Cells | Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrins... | 2023 | J Immunother Cancer | Li J. et al. | DOI: 10.1136/jitc-2023-007625 |
Blasticidin | Oxidative and ER stress by elevated insulin biosynthesis and palmitic acid in... | 2024 | J Mol Endocrinol. | Vidrio-Huerta B. et al. | DOI: 10.1530/JME-23-0087 |
LumiKine™ Xpress hIFN-β 2.0 | Involvement of Interferon Regulatory Factor 7 in Nicotine's Suppression of An... | 2019 | J Neuroimmune Pharmacol. | Han H. et al. | DOI: 10.1007/s11481-019-09845-2 |
LumiKine™ Xpress hIFN-α 2.0 | Involvement of Interferon Regulatory Factor 7 in Nicotine's Suppression of An... | 2019 | J Neuroimmune Pharmacol. | Han H. et al. | DOI: 10.1007/s11481-019-09845-2 |
ssPolyU Naked | Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-l... | 2021 | Nat Commun. | Ban T. et al. | DOI: 10.1038/s41467-021-24609-4 |
LumiKine™ Xpress hIFN-α 2.0 | Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-l... | 2021 | Nat Commun. | Ban T. et al. | DOI: 10.1038/s41467-021-24609-4 |
LPS-EB (LPS from E. coli O111:B4) | The circadian regulator PER1 promotes cell reprogramming by inhibiting inflam... | 2023 | PLoS Biol. | Katoku-Kikyo N. et al. | DOI: 10.1371/journal.pbio.3002419 |
MycoStrip® - Mycoplasma Detection Kit | INX-315, a selective CDK2 inhibitor, induces cell cycle arrest and senescence... | 2023 | Cancer Discov. | Dietrich C. et al. | DOI: 10.1158/2159-8290.CD-23-0954 |
Alhydrogel® adjuvant 2% | Identification of four neutralizing antigenic sites on the enterovirus D68 ca... | 2023 | J Virol. | Dai W. et al. | DOI: 10.1128/jvi.01600-23 |
Poly(I:C) LMW | The transcription factor Aiolos restrains the activation of intestinal intrae... | 2024 | Nat Immunol. | Yomogida K. et al. | DOI: 10.1038/s41590-023-01693-w |
R848 (Resiquimod) | A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenic... | 2024 | Antimicrob Agents Chemother. | Kirkland M.E. et al. | DOI: 10.1128/aac.00598-23 |
Alhydrogel® adjuvant 2% | The Group A Streptococcal Vaccine Candidate VAX-A1 Protects against Group B S... | 2023 | Vaccines (Basel) | McCabe S. et al. | DOI: 10.3390/vaccines11121811 |
Poly(I:C) (HMW) VacciGrade™ | Potential of Nucleic Acid Receptor Ligands to Improve Vaccination Efficacy ag... | 2023 | Vaccines (Basel) | Scheunemann J.F. et al. | DOI: 10.3390/vaccines11050966 |
NLRP3 inflammasome inhibitor - MCC950 | Inflammasome Activation and IL-1β Release Triggered by Nanosecond Pulsed Elec... | 2024 | J Immunol. | Mazzarda F. et al. | DOI: 10.4049/jimmunol.2200881 |
LPS-PG (Lipopolysaccharide from P. gingivalis) | Disruption of cholesterol homeostasis triggers periodontal inflammation and a... | 2023 | Exp Mol Med. | Tran T.T. et al. | DOI: 10.1038/s12276-023-01122-w |
Puromycin | The linear ANRIL transcript P14AS regulates the NF-κB signaling to promote co... | 2023 | Mol Med. | Ma W. & Hu J. | DOI: 10.1186/s10020-023-00761-z |
Poly(I:C) (HMW) VacciGrade™ | Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses pr... | 2023 | J Clin Invest. | Kawai A. et al. | DOI: 10.1172/JCI166827 |